Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes
Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes
Active, not recruiting · NCT06723795 · Registry updated 2026-08-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, chronic obstructive pulmonary disease, disease, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Not applicable | 2026-08-25 | NCT06723795 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Tel-Aviv Sourasky Medical Center | 55 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tel-Aviv Sourasky Medical Center | Tel Aviv | Israel | 7 |